Skip to main content
. 2023 Jun 29;11(7):1861. doi: 10.3390/biomedicines11071861

Figure 11.

Figure 11

Analysis results for immune cell subcomponent types and tumor drug resistance. (I): Heat map of clinically relevant prognostic factors; (II): Analysis of prognostic subsets of immune cells; (ai): Analysis of immune cell subsets associated with high and low risk prognosis.